Market closedNon-fractional
AtriCure/ATRC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About AtriCure
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
Ticker
ATRC
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Mason, United States
Employees
1,200
Website
www.atricure.com
AtriCure Metrics
BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$0.80
EPS
1.37
Beta
-
Dividend rate
Price and volume
Market cap
$1.1B
Beta
1.37
Financial strength
Current ratio
4.004
Quick ratio
2.633
Long term debt to equity
15.959
Total debt to equity
16.516
Interest coverage (TTM)
-5.23%
Management effectiveness
Return on assets (TTM)
-3.86%
Return on equity (TTM)
-8.17%
Valuation
Price to revenue (TTM)
2.637
Price to book
2.43
Price to tangible book (TTM)
6.95
Price to free cash flow (TTM)
-44.22
Growth
Revenue change (TTM)
18.70%
Earnings per share change (TTM)
-3.13%
3-year revenue growth (CAGR)
24.94%
3-year earnings per share growth (CAGR)
-10.35%
What the Analysts think about AtriCure
Analyst Ratings
Majority rating from 9 analysts.
AtriCure Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$109M
2.16%
Net income
-$13M
36.08%
Profit margin
-12.13%
33.30%
AtriCure Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.11
-$0.20
-$0.21
-$0.28
-
Expected
-$0.30
-$0.31
-$0.23
-$0.23
-$0.17
Surprise
-62.77%
-35.79%
-8.50%
22.57%
-
AtriCure News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AtriCure stock?
AtriCure (ATRC) has a market cap of $1.1B as of July 26, 2024.
What is the P/E ratio for AtriCure stock?
The price to earnings (P/E) ratio for AtriCure (ATRC) stock is 0 as of July 26, 2024.
Does AtriCure stock pay dividends?
No, AtriCure (ATRC) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next AtriCure dividend payment date?
AtriCure (ATRC) stock does not pay dividends to its shareholders.
What is the beta indicator for AtriCure?
AtriCure (ATRC) has a beta rating of 1.37. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell AtriCure stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.